Ideal Combination of Oral Hypoglycemic Agents for Patients with Type 2 Diabetes Mellitus

被引：0
|
作者：
Kim, Hye Soon [1 ]
机构：
[1] Keimyung Univ, Sch Med, Dept Internal Med, 1095 Dalgubeol Daero, Daegu 42601, South Korea
来源：
DIABETES & METABOLISM JOURNAL | 2024年 / 48卷 / 05期
关键词：
D O I：
10.4093/dmj.2024.0479
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：882 / 884
页数：3
相关论文
共 50 条
  • [1] Combination therapy of oral hypoglycemic agents in patients with type 2 diabetes mellitus
    Moon, Min Kyong
    Hur, Kyu Yeon
    Ko, Seung-Hyun
    Park, Seok-O
    Lee, Byung-Wan
    Kim, Jin Hwa
    Rhee, Sang Youl
    Kim, Hyun Jin
    Choi, Kyung Mook
    Kim, Nan-Hee
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2017, 32 (06): : 974 - 983
  • [2] Combination Therapy of Oral Hypoglycemic Agents in Patients with Type 2 Diabetes Mellitus
    Moon, Min Kyong
    Hur, Kyu-Yeon
    Ko, Seung-Hyun
    Park, Seok-O
    Lee, Byung-Wan
    Kim, Jin Hwa
    Rhee, Sang Youl
    Kim, Hyun Jin
    Choi, Kyung Mook
    Kim, Nan-Hee
    DIABETES & METABOLISM JOURNAL, 2017, 41 (05) : 357 - 366
  • [3] Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
    Romera, Irene
    Ampudia-Blasco, Francisco Javier
    Perez, Antonio
    Arino, Bernat
    Pfarr, Egon
    Kis, Sanja Giljanovic
    Naderali, Ebrahim
    ENDOCRINOLOGIA Y NUTRICION, 2016, 63 (10): : 519 - 526
  • [4] Determinants of failure of oral hypoglycemic agents in patients with type 2 diabetes mellitus
    DeValk, H
    VanLeeuwen, JT
    Blankestijn, HG
    DeBruin, HJ
    Erkelens, DW
    DIABETES, 1996, 45 : 964 - 964
  • [5] Risk of Pancreatic Adenocarcinoma in Patients on Oral Hypoglycemic Agents for Type 2 Diabetes Mellitus
    Babajide, Oyedotun
    Desai, Aakash
    Adekunle, Ayooluwatomiwa
    Youssef, Michael
    Sedarous, Mary
    Lawendy, Bishoy
    Okafor, Philip
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S73 - S74
  • [6] Combinations of insulin and oral hypoglycemic agents in diabetes mellitus type 2
    Pagkalos, Emmanouil M.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2011, 93 : S100 - S101
  • [7] Basal insulin in combination with oral Hypoglycemic agents in the management of type 2 diabetes
    Springer, J
    DIABETES EDUCATOR, 2004, 30 (01): : 68 - 70
  • [8] PHARMACOECONOMIC EVALUATION OF THE ORAL HYPOGLYCEMIC AGENTS IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS IN THE RUSSIAN FEDERATION
    Ryazhenov, V. V.
    Emchenko, I., V
    VALUE IN HEALTH, 2013, 16 (07) : A440 - A440
  • [9] Hypoglycemic Agents in the Management of Type 2 Diabetes Mellitus
    Ho, Josephine
    Leung, Alexander K. C.
    Rabi, Doreen
    RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY, 2011, 5 (01) : 66 - 73
  • [10] ORAL HYPOGLYCEMIC AGENTS IN TYPE-II DIABETES-MELLITUS
    LUBBOS, H
    MILLER, JL
    ROSE, LI
    AMERICAN FAMILY PHYSICIAN, 1995, 52 (07) : 2075 - 2078
12345